Common questions about DOT and non-DOT drug and alcohol testing.

DOT drug testing applies to employees in safety-sensitive positions regulated by a DOT agency. This includes commercial motor vehicle drivers (FMCSA), aviation personnel (FAA), mass transit workers (FTA), pipeline operators (PHMSA), railroad employees (FRA), and certain maritime workers (USCG). If your role is designated safety-sensitive under any of these agencies, federal testing requirements apply.

The federally mandated DOT drug test screens for five substance categories: marijuana (THC), cocaine, opioids (including codeine, morphine, heroin, oxycodone, oxymorphone, hydrocodone, and hydromorphone), amphetamines (including methamphetamine and MDMA), and phencyclidine (PCP). The panel is set by the Department of Transportation and cannot be modified by employers.

Under 49 CFR Part 40, all DOT urine specimens must be analyzed at a laboratory certified by the Substance Abuse and Mental Health Services Administration (SAMHSA). These laboratories meet strict federal standards for testing accuracy, chain of custody handling, and quality control. Results from non-certified labs are not valid for DOT compliance purposes.

A Medical Review Officer is a licensed physician trained to review DOT drug test results. When a laboratory reports a non-negative result, the MRO contacts the donor directly to determine whether a legitimate medical explanation exists — such as a valid prescription — before reporting the final result to the employer. This step is required on every DOT drug test result, including negative ones.

DOT regulations require testing under six specific circumstances: pre-employment (before an employee performs safety-sensitive duties), random (unannounced, at federally mandated rates), post-accident (following qualifying incidents), reasonable suspicion (based on specific observations by a trained supervisor), return-to-duty (after a violation, before resuming safety-sensitive work), and follow-up (ongoing unannounced testing after return-to-duty).

A non-negative result is first reviewed by the MRO. If confirmed as a verified positive, the employee must be immediately removed from safety-sensitive duties. The employer is notified and the employee is referred to a Substance Abuse Professional (SAP). The employee cannot return to safety-sensitive work until completing the SAP evaluation and any required treatment, passing a return-to-duty test, and completing a follow-up testing program.

All DOT urine collections are split into two sealed bottles — Bottle A (the primary specimen) and Bottle B (the split). If the MRO reports a verified positive, adulterated, or substituted result, the donor has 72 hours to request that the split specimen be tested at a second SAMHSA-certified laboratory. The split test result can confirm or challenge the primary result.

Under DOT regulations, a confirmed breath alcohol concentration (BAC) of 0.04 or greater is a violation. The employee must be immediately removed from safety-sensitive duties and referred to a Substance Abuse Professional before any return-to-duty testing can occur.

A confirmed result between 0.02 and 0.039 BAC is not a DOT violation but triggers a mandatory temporary removal from safety-sensitive duties. The employee cannot return to those duties for a minimum of eight hours or until a subsequent test shows a result below 0.02. This is not subject to the same SAP referral process as a 0.04+ result.

An EBT is a breath alcohol testing device approved by the National Highway Traffic Safety Administration (NHTSA) for use in DOT testing programs. Only NHTSA-approved devices can be used for DOT confirmation tests. EBTs measure BAC from a breath sample and print a result record that serves as the official documentation for compliance purposes.

DOT regulations require a two-step process. A screening test is performed first. If the result is below 0.02, the process ends with a negative result. If the result is 0.02 or greater, a confirmation test must be conducted at least 15 minutes later on the same EBT device. Only the confirmation result is used to determine whether a violation or cautionary action applies. This two-step process protects accuracy.

Refusing a DOT-required alcohol test is treated the same as a positive result under 49 CFR Part 40. The employee is removed from safety-sensitive duties, referred to a Substance Abuse Professional, and subject to the same return-to-duty requirements as a confirmed violation. Refusal includes failing to appear, failure to provide a sufficient breath sample without a medical explanation, and leaving the collection site without authorization.

Non-DOT drug testing refers to any employer-administered drug screening program that is not governed by a federal transportation agency regulation. Employers create their own drug-free workplace policies and determine which substances to test for, when testing occurs, and what consequences follow a positive result. Non-DOT testing must still comply with applicable state laws but is otherwise flexible in design.

Non-DOT testing offers flexibility in panel selection. The most common options are the 5-panel (same substances as DOT), the 10-panel (adds barbiturates, benzodiazepines, methadone, propoxyphene, and methaqualone), and the 12-panel (adds oxycodone and buprenorphine). Employers can select the panel that best aligns with their workplace risk profile and industry requirements.

Non-DOT testing is appropriate for any employer whose workforce is not subject to federal transportation agency mandates. This includes most private-sector businesses, construction companies, healthcare organizations, staffing agencies, and any employer that wants to maintain a drug-free workplace policy. It is also used for court-ordered testing, professional licensing requirements, and personal screening.

MRO review is not federally required for non-DOT testing, but it is available and strongly recommended. Having an MRO review non-negative results before an employer receives them provides an important safeguard — it ensures that legitimate medical explanations are considered and reduces the risk of adverse employment action based on an inaccurate result.

DOT testing is federally mandated with fixed procedures — a specific 5-panel urine test, SAMHSA-certified laboratory, federal CCF documentation, and mandatory MRO review. Non-DOT testing is employer-defined with more flexibility in panel selection, documentation, and result handling. DOT and non-DOT tests cannot be combined or interchanged; they serve different regulatory purposes and use different chain of custody forms.

Non-DOT alcohol testing uses the same EBT device and breath collection method, but the threshold for action and the required procedures are set by the employer's policy rather than federal regulation. Employers can define their own BAC cut-off levels, determine whether a single-step or two-step process is used, and establish their own consequences for a positive result. The 0.04 DOT violation threshold does not automatically apply to non-DOT programs.

The threshold is determined by the employer's written drug and alcohol policy. Some employers align their threshold with the DOT standard of 0.04, while others set a lower limit such as 0.02 or a zero-tolerance standard. It is important that the policy threshold is clearly documented before testing begins, as it defines what constitutes a policy violation and what consequences follow.

Yes, provided the employer's drug and alcohol policy is clearly written, consistently applied, and compliant with applicable state laws. Employers should consult legal counsel when establishing their policy to ensure that testing procedures, thresholds, and consequences are documented and defensible. State laws vary on when and how alcohol testing can be conducted and what actions can be taken based on results.

Use the scheduling page to submit a request. Include the service type, whether the appointment is for a business or individual, your preferred date, and any mobile location details if on-site service is needed. A confirmation will follow to finalize timing and logistics before the visit.

Yes. In addition to scheduled appointments, on-call and after-hours service is available for post-accident collections, reasonable suspicion testing, and other time-sensitive situations. After-hours testing is available when standard business hours don't fit the need — including evenings and weekends. Call (540) 623-7063 directly for urgent or after-hours testing needs.

Bring a valid government-issued photo ID such as a driver's license, state ID, or passport. If the test is employer-ordered, bring any paperwork or authorization provided by your employer. Avoid excessive hydration before a urine collection and refrain from using tobacco, alcohol, or strong mouthwash before a breath alcohol test.

Breath alcohol test results are available immediately on-site. Urine drug test results for negative specimens typically return within 24 to 48 hours after the laboratory receives the specimen. Non-negative results take longer due to the required confirmation testing and MRO review process, which can add several business days depending on donor contact and documentation requirements.

Yes. Mobile on-site service brings testing directly to your office, job site, fleet yard, or any approved location. All collection supplies and documentation are provided on arrival. A private space suitable for specimen collection must be available at the site. Mobile service is ideal for random testing programs, post-accident collections, and multi-employee pre-employment testing. Contact us to confirm location and scheduling.